Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Medical ImagingMolecular Imaging

PUBLISHER: MarketsandMarkets | PRODUCT CODE: 1019458

Cover Image

PUBLISHER: MarketsandMarkets | PRODUCT CODE: 1019458

Contrast Media/Contrast Agent Market by Type (Iodinated Contrast Media), Modality (X-Ray/CT, MRI, and Ultrasound), Application (Radiology), End User (Hospitals), Indication (Cancer), Route of Administration (Oral), Region - Global Forecast to 2026

PUBLISHED:
PAGES: 287 Pages
DELIVERY TIME: 1-2 business days
Get a Free Sample
Get More Info
SELECT AN OPTION
PDF (Single User License)
USD 4950
PDF (5-user License)
USD 6650
PDF (Corporate License)
USD 8150
PDF (Global License)
USD 10000

Add to Cart

Description

Table of Contents

The global contrast media/ contrast agents market is projected to reach USD 5.9 billion by 2026 from USD 4.9 billion in 2021, at a CAGR of 3.7% during the forecast period. The growth in this market can be attributed to the rising prevalence of chronic diseases, growing approvals of contrast agents, rising volume of CT and MRI examinations performed, growing number of diagnostic centers and hospitals, and availability of reimbursement. Emerging markets in Asian countries are expected to offer strong growth opportunities for players in the market. In contrast, high cost and inaccessibility of advanced therapeutics may restrict market growth to a certain extent. The contrast media/ contrast agents market is segmented based on type, modality, route of administration, indication, application, end user, and region.

"Iodinated contrast media segment is expected to dominate the market during the forecast period."

Based on type, the contrast media/ contrast agents market is segmented into iodinated contrast media, gadolinium-based contrast media, microbubble contrast media, and barum-based contrast media. Iodinated contrast media account for the largest share of the contrast media/ contrast agents market. The large share of this segment can be attributed to the growing number of angioplasty procedures performed globally.

"X-ray/ CT segment to dominate the market during the forecast period."

Based on modality, contrast media/ contrast agents can be segmented into X-ray/CT, MRI and Ultrasound.X-ray/CT account for the largest share of the contrast media/ contrast agents market. The large share of this segment can be attributed to the increasing number of CT examinations across the globe, coupled with advancements in CT imaging technologies that majorly use injectable contrast media.

"Intravascular route segment holds highest market share during the forecast period and is also expected to grow at the highest CAGR during the forecast period."

Based on routes of administration, the contrast media/contrast agents market is segmented into oral, intravascular, rectal, and other routes of administration. The intravascular route segment is expected to hold majority of market share and have highest growth rate. The widespread use of injectable contrast media in most modern imaging modalities, such as CT and MRI scanning, is one of the major factors driving the growth of the intravascular segment.

"Cardiovascular disorders segment holds highest market share during the forecast period and is also expected to grow at the highest CAGR during the forecast period."

Based on indication, the contrast media/contrast agents market has been segmented into cardiovascular disorders, cancer, gastrointestinal disorders, musculoskeletal disorders, neurological disorders, and nephrological disorders. Cardiovascular disorders accounted for the largest market share and highest growth rate. The large share of this segment can be attributed to the rising geriatric population and the increasing prevalence of CVD across the globe.

"Radiology segment to dominate the market during the forecast period."

Based on application, the contrast media/contrast agents market is segmented into radiology, interventional radiology, and interventional cardiology.The radiology applications segment commanded the largest share of the contrast media/contrast agents market. .The large share of this segment can be attributed to the increasing use of medical imaging techniques, such as X-ray, CT, MRI, and ultrasound, in these applications.

"Hospitals, Clinics & Ambulatory Surgery Centers segment to dominate the market during the forecast period."

Based on end user, the contrast media/contrast agents market is segmented into hospitals, clinics, and ASCs and diagnostic imaging centers. Hospitals, clinics, and ASCs for the largest share of the contrast media/ contrast agents market. The large share is attributed to rising number of hospitals across the globe.

"North America will dominate the market during the forecast period."

The global contrast media/ contrast agents market is segmented into North America (the US and Canada), Europe (Germany, the UK, France, Italy, Spain and the Rest of Europe), Asia Pacific (Japan, China, India, and the Rest of Asia Pacific), Latin America and Middle East & Africa. In 2020, North America dominated the global contrast media/ contrast agents market, followed by Europe. The large share of the North American market can be attributed to the presence of major players in the region, high prevalence of chronic disorders, growing geriatric population, and the increasing adoption of minimally invasive procedures.

The primary interviews conducted for this report can be categorized as follows:

  • By Company Type -Tier 1: 55%,Tier 2: 25% and Tier 20%
  • By Designation - C-level:43%, D-level:32%, and Others:25%
  • By Region - North America:38%, Europe:23%, Asia Pacific:29%, Latin America: 7%, and Middle East & Africa: 3%

List of Companies Profiled in the Report

  • GE Healthcare (US)
  • Bracco Imaging SPA (Italy)
  • Bayer AG (Germany)
  • Guerbet (France)
  • Lantheus Medical Imaging, Inc. (US)
  • Unijules Life Sciences (India)
  • J.B. Chemicals and Pharmaceuticals Ltd. (India)
  • SANOCHEMIA Pharmazeutika GmbH (Austria)
  • Taejoon Pharm (South Korea)
  • JodasExpoim (India)
  • Nano Therapeutics Pvt. Ltd. (India)
  • Kiran X-ray (India)
  • iMax Diagnostic Imaging Limited (Ireland)
  • YZJ Group (China)
  • Livealth Biopharma Pvt. Ltd. (India)
  • Trivitron Healthcare Pvt. Ltd. (India)
  • Novalek Pharmaceuticals Pvt. Ltd. (India)
  • Unispire Biopharma Private Limited (India)
  • Acro Lifesciences (I) Pvt. Ltd. (India)
  • Congruent Pharmachem Private Limited (India)
  • Stanex Drugs & Chemical Pvt. Ltd. (India)
  • Beijing Beilu Pharmaceutical Co., Ltd. (China)
  • Rege Imaging & Cine Films Private Limited (India)
  • K DIAM EXIM (India)
  • Onko Ilac San. ve Tic. A.S. (Turkey)
  • Subhra Pharma Pvt. Ltd. (India)

Research Coverage:

This report provides a detailed picture of the global contrast media/ contrast agentsmarket. It aims at estimating the size and future growth potential of the market across different segments, such astype, modality, route of administration, indication, application, end userand region. The report also analyzes factors (such as drivers, restraints,opportunities and challenges) affecting market growth. It evaluates the opportunities in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total contrast media/ contrast agents market. The report forecasts the revenue of the market segments with respect to four major regions.

Reasons to Buy the Report:

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on contrast media/ contrast agents offered by the top 26 players in the contrast media/ contrast agents market. The report analyses the contrast media/ contrast agentsmarket by product, modality, route of administration, indication, application, end userand region.
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various contrast media/ contrast agentsacross key geographic regions.
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the contrast media/ contrast agentsmarket.
  • Competitive Assessment: In-depth assessment of market ranking and strategies of the leading players in the contrast media/ contrast agentsmarket.
Show more
Product Code: MD 3577

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY
  • 1.3 MARKET SCOPE
    • FIGURE 1 CONTRAST MEDIA/CONTRAST AGENTS MARKET SEGMENTATION
    • 1.3.1 YEARS CONSIDERED FOR THE STUDY
  • 1.4 CURRENCY
  • 1.5 STAKEHOLDERS
  • 1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 2 RESEARCH DESIGN
  • 2.2 SECONDARY DATA
    • 2.2.1 SECONDARY SOURCES
  • 2.3 PRIMARY DATA
    • FIGURE 3 PRIMARY SOURCES
    • 2.3.1 KEY DATA FROM PRIMARY SOURCES
    • 2.3.2 KEY INDUSTRY INSIGHTS
    • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • 2.4 MARKET SIZE ESTIMATION
    • FIGURE 5 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
    • 2.4.1 GROWTH FORECAST
    • FIGURE 6 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
    • FIGURE 7 TOP-DOWN APPROACH
  • 2.5 MARKET BREAKDOWN AND DATA TRIANGULATION
    • FIGURE 8 DATA TRIANGULATION METHODOLOGY
  • 2.6 MARKET SHARE ANALYSIS
  • 2.7 ASSUMPTIONS FOR THE STUDY
    • 2.7.1 COVID-19 SPECIFIC ASSUMPTIONS
  • 2.8 LIMITATIONS
  • 2.9 RISK ASSESSMENT
  • 2.10 GROWTH RATE ASSUMPTIONS
  • 2.11 COVID-19 ECONOMIC ASSESSMENT
  • 2.12 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO
    • FIGURE 9 CRITERIA IMPACTING THE GLOBAL ECONOMY
    • FIGURE 10 RECOVERY SCENARIO OF THE GLOBAL ECONOMY

3 EXECUTIVE SUMMARY

    • FIGURE 11 CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)
    • FIGURE 12 CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY MODALITY, 2021 VS. 2026 (USD MILLION)
    • FIGURE 13 CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2021 VS. 2026 (USD MILLION)
    • FIGURE 14 CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY INDICATION, 2021 VS. 2026 (USD MILLION)
    • FIGURE 15 CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY APPLICATION, 2021 VS. 2026 (USD MILLION)
    • FIGURE 16 CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY END USER, 2021 VS. 2026 (USD MILLION)
    • FIGURE 17 CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY REGION, 2021 VS. 2026 (USD MILLION)

4 PREMIUM INSIGHTS

  • 4.1 CONTRAST MEDIA/CONTRAST AGENTS MARKET OVERVIEW
    • FIGURE 18 INCREASING INCIDENCE OF CHRONIC DISORDERS TO DRIVE MARKET GROWTH
  • 4.2 CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY TYPE (2021-2026)
    • FIGURE 19 MICROBUBBLE CONTRAST MEDIA SEGMENT TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • 4.3 NORTH AMERICA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY TYPE AND COUNTRY (2020)
    • FIGURE 20 THE US DOMINATED THE NORTH AMERICAN CONTRAST MEDIA/CONTRAST AGENTS MARKET IN 2020
  • 4.4 CONTRAST MEDIA/CONTRAST AGENTS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
    • FIGURE 21 INDIA AND CHINA TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
    • FIGURE 22 CONTRAST MEDIA/CONTRAST AGENTS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Rising prevalence of chronic diseases
    • TABLE 1 INCIDENCE OF CANCER, BY REGION, 2020 VS. 2030 VS. 2040 (MILLION)
      • 5.2.1.2 Growing approvals of contrast agents
      • 5.2.1.3 Rising volume of CT and MRI examinations performed
    • TABLE 2 NUMBER OF MRI EXAMS PERFORMED PER 1,000 INHABITANTS, BY COUNTRY, 2010 VS. 2018
    • TABLE 3 NUMBER OF CT EXAMS PERFORMED PER 1,000 INHABITANTS, BY COUNTRY, 2010 VS. 2018
      • 5.2.1.4 Growing number of diagnostic centers and hospitals
      • 5.2.1.5 Availability of reimbursement
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Side-effects and allergic reactions associated with contrast agents
    • TABLE 4 LIST OF SIDE-EFFECTS/REACTIONS TO CONTRAST MEDIA
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Generic contrast media
      • 5.2.3.2 Increasing research on contrast agents
    • TABLE 5 INDICATIVE LIST OF RESEARCH STUDIES
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Technological advancements in imaging solutions
      • 5.2.4.2 Restriction and withdrawal of linear gadolinium-based contrast agents
      • 5.2.4.3 Dearth of trained professionals
    • TABLE 6 METROPOLITAN AREAS IN THE US WITH HIGH EMPLOYMENT LEVELS AMONG RADIOLOGY TECHNOLOGISTS AND TECHNICIANS
  • 5.3 RANGES/SCENARIOS
    • 5.3.1 CONTRAST MEDIA/CONTRAST AGENTS MARKET FORECAST
    • FIGURE 23 PESSIMISTIC SCENARIO
    • FIGURE 24 OPTIMISTIC SCENARIO
    • FIGURE 25 REALISTIC SCENARIO
  • 5.4 COVID-19 IMPACT ON THE CONTRAST MEDIA/CONTRAST AGENTS MARKET
  • 5.5 TRENDS/DISRUPTIONS IMPACTING CUSTOMER'S BUSINESS
    • 5.5.1 REVENUE SHIFT & REVENUE POCKETS FOR CONTRAST MEDIA/CONTRAST AGENT MANUFACTURERS
    • 5.5.2 REVENUE SHIFT FOR CONTRAST MEDIA/CONTRAST AGENTS MARKET
  • 5.6 PRICING ANALYSIS
    • TABLE 7 PRICES OF CONTRAST MEDIA/CONTRAST AGENTS
  • 5.7 SUPPLY CHAIN ANALYSIS
    • FIGURE 26 DIRECT DISTRIBUTION: A STRATEGY PREFERRED BY PROMINENT COMPANIES
  • 5.8 VALUE CHAIN ANALYSIS
    • FIGURE 27 VALUE CHAIN ANALYSIS: MAJOR VALUE IS ADDED DURING THE DEVELOPMENT PHASE
  • 5.9 ECOSYSTEM ANALYSIS
    • 5.9.1 ROLE IN THE ECOSYSTEM
    • TABLE 8 ROLE OF KEY PLAYERS IN THE ECOSYSTEM
    • FIGURE 28 KEY PLAYERS IN THE CONTRAST MEDIA/CONTRAST AGENTS ECOSYSTEM
  • 5.10 TECHNOLOGY ANALYSIS
  • 5.11 PATENT ANALYSIS
  • 5.12 TRADE ANALYSIS
    • TABLE 9 IMPORT DATA FOR OPACIFYING PREPARATIONS FOR X-RAY EXAMINATIONS; DIAGNOSTIC REAGENTS FOR ADMINISTRATION TO PATIENTS, BY COUNTRY, 2016-2020 (USD MILLION)
    • TABLE 10 EXPORT DATA FOR OPACIFYING PREPARATIONS FOR X-RAY EXAMINATIONS; DIAGNOSTIC REAGENTS FOR ADMINISTRATION TO PATIENTS, BY COUNTRY, 2016-2020 (USD MILLION)
  • 5.13 REGULATORY LANDSCAPE
    • TABLE 11 LIST OF REGULATORY AUTHORITIES IN THE PHARMACEUTICAL INDUSTRY
    • 5.13.1 EU REGULATIONS
    • 5.13.2 FDA REGULATIONS
    • 5.13.3 JPMA REGULATIONS
  • 5.14 PORTER'S FIVE FORCES ANALYSIS
    • TABLE 12 PORTER'S FIVE FORCES
    • 5.14.1 INTENSITY OF COMPETITIVE RIVALRY
    • 5.14.2 BARGAINING POWER OF SUPPLIERS
    • 5.14.3 BARGAINING POWER OF BUYERS
    • 5.14.4 THREAT OF SUBSTITUTES
    • 5.14.5 THREAT OF NEW ENTRANTS

6 CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY TYPE

  • 6.1 INTRODUCTION
  • 6.2 PRIMARY NOTES
    • TABLE 13 CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY TYPE, 2017-2019 (USD MILLION)
    • TABLE 14 CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY TYPE, 2020-2026 (USD MILLION)
  • 6.3 IODINATED CONTRAST MEDIA
    • 6.3.1 CONSUMPTION OF IODINATED CONTRAST MEDIA IS HIGH DUE TO THE HIGHER DOSAGE REQUIRED IN CT SCANS-A KEY FACTOR DRIVING MARKET GROWTH
    • TABLE 15 IODINATED CONTRAST MEDIA MARKET, BY REGION, 2017-2019 (USD MILLION)
    • TABLE 16 IODINATED CONTRAST MEDIA MARKET, BY REGION, 2020-2026 (USD MILLION)
  • 6.4 GADOLINIUM-BASED CONTRAST MEDIA
    • 6.4.1 SUSPICION REGARDING THE SAFETY PROFILE OF GADOLINIUM-BASED CONTRAST AGENTS TO CHALLENGE MARKET GROWTH TO A CERTAIN EXTENT
    • TABLE 17 GADOLINIUM-BASED CONTRAST MEDIA MARKET, BY REGION, 2017-2019 (USD MILLION)
    • TABLE 18 GADOLINIUM-BASED CONTRAST MEDIA MARKET, BY REGION, 2020-2026 (USD MILLION)
  • 6.5 MICROBUBBLE CONTRAST MEDIA
    • 6.5.1 MICROBUBBLES ARE CONVENIENT, COMPLETELY RADIATION-FREE, AND VERSATILE, MAKING THEM EXTREMELY POPULAR WITH PHYSICIANS WORLDWIDE
    • TABLE 19 MICROBUBBLE CONTRAST MEDIA MARKET, BY REGION, 2017-2019 (USD MILLION)
    • TABLE 20 MICROBUBBLE CONTRAST MEDIA MARKET, BY REGION, 2020-2026 (USD MILLION)
  • 6.6 BARIUM-BASED CONTRAST MEDIA
    • 6.6.1 BARIUM-BASED CONTRAST MEDIA CAN CAUSE ADVERSE EFFECTS IN PATIENTS LIKE PERFORATION OF THE PERITONEUM-THIS IS EXPECTED TO NEGATIVELY IMPACT THE MARKET
    • TABLE 21 BARIUM-BASED CONTRAST MEDIA MARKET, BY REGION, 2017-2019 (USD MILLION)
    • TABLE 22 BARIUM-BASED CONTRAST MEDIA MARKET, BY REGION, 2020-2026 (USD MILLION)

7 CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY MODALITY

  • 7.1 INTRODUCTION
  • 7.2 PRIMARY NOTES
    • TABLE 23 CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY MODALITY, 2017-2019 (USD MILLION)
    • TABLE 24 CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY MODALITY, 2020-2026 (USD MILLION)
  • 7.3 X-RAY/CT
    • 7.3.1 X-RAY/CT SEGMENT ACCOUNTS FOR THE LARGEST SHARE OF THE CONTRAST MEDIA/CONTRAST AGENTS MARKET
    • TABLE 25 NUMBER OF X-RAY AND CT SCANS IN ENGLAND
    • TABLE 26 INSTALLED BASE OF CT SCANNERS, BY REGION, 2017 VS. 2018
    • TABLE 27 CT PROCEDURAL VOLUMES, BY REGION, 2017 VS. 2018 (MILLION)
    • TABLE 28 X-RAY/CT CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY REGION, 2017-2019 (USD MILLION)
    • TABLE 29 X-RAY/CT CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY REGION, 2020-2026 (USD MILLION)
  • 7.4 MAGNETIC RESONANCE IMAGING
    • 7.4.1 GROWING NUMBER OF MRI SCANNERS AND INCREASING MRI EXAMINATIONS ARE DRIVING MARKET GROWTH
    • TABLE 30 INSTALLED BASE OF MRI SYSTEMS, BY REGION, 2017 VS. 2018
    • TABLE 31 MRI PROCEDURAL VOLUMES, BY REGION, 2017 VS. 2018 (MILLION)
    • TABLE 32 NUMBER OF MRI PROCEDURES IN ENGLAND
    • TABLE 33 MRI CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY REGION, 2017-2019 (USD MILLION)
    • TABLE 34 MRI CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY REGION, 2020-2026 (USD MILLION)
  • 7.5 ULTRASOUND
    • 7.5.1 ULTRASOUND SEGMENT TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
    • TABLE 35 NUMBER OF ULTRASOUND PROCEDURES IN ENGLAND
    • TABLE 36 ULTRASOUND CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY REGION, 2017-2019 (USD MILLION)
    • TABLE 37 ULTRASOUND CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY REGION, 2020-2026 (USD MILLION)

8 CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION

  • 8.1 INTRODUCTION
    • TABLE 38 CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2017-2019 (USD MILLION)
    • TABLE 39 CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2026 (USD MILLION)
  • 8.2 INTRAVASCULAR ROUTE
    • 8.2.1 WIDESPREAD USE OF INTRAVASCULAR ROUTES OF ADMINISTRATION IN IMAGING MODALITIES TO DRIVE MARKET GROWTH
      • 8.2.1.1 INTRAVENOUS (IV) ROUTE
      • 8.2.1.2 INTRA-ARTERIAL (IA) ROUTE
    • TABLE 40 INTRAVASCULAR CONTRAST MEDIA MARKET, BY REGION, 2017-2019 (USD MILLION)
    • TABLE 41 INTRAVASCULAR CONTRAST MEDIA MARKET, BY REGION, 2020-2026 (USD MILLION)
  • 8.3 ORAL ROUTE
    • 8.3.1 USE OF ORAL CONTRAST MEDIA CAN LEAD TO PERFORATIONS IN THE GIT, LEADING TO PERITONITIS-THIS MAY LIMIT MARKET GROWTH TO A CERTAIN EXTENT
    • TABLE 42 ORAL CONTRAST MEDIA MARKET, BY REGION, 2017-2019 (USD MILLION)
    • TABLE 43 ORAL CONTRAST MEDIA MARKET, BY REGION, 2020-2026 (USD MILLION)
  • 8.4 RECTAL ROUTE
    • 8.4.1 MILD DISCOMFORT ASSOCIATED WITH RECTAL CONTRAST MEDIA TO LIMIT MARKET GROWTH
    • TABLE 44 RECTAL CONTRAST MEDIA MARKET, BY REGION, 2017-2019 (USD MILLION)
    • TABLE 45 RECTAL CONTRAST MEDIA MARKET, BY REGION, 2020-2026 (USD MILLION)
  • 8.5 OTHER ROUTES OF ADMINISTRATION
    • TABLE 46 OTHER CONTRAST MEDIA MARKET, BY REGION, 2017-2019 (USD MILLION)
    • TABLE 47 OTHER CONTRAST MEDIA MARKET, BY REGION, 2020-2026 (USD MILLION)

9 CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY INDICATION

  • 9.1 INTRODUCTION
  • 9.2 PRIMARY NOTES
    • TABLE 48 CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY INDICATION, 2017-2019 (USD MILLION)
    • TABLE 49 CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY INDICATION, 2020-2026 (USD MILLION)
  • 9.3 CARDIOVASCULAR DISORDERS
    • 9.3.1 CARDIOVASCULAR DISORDERS SEGMENT TO DOMINATE THE CONTRAST MEDIA/CONTRAST AGENTS MARKET
    • TABLE 50 CONTRAST MEDIA/CONTRAST AGENTS MARKET FOR CARDIOVASCULAR DISORDERS, BY REGION, 2017-2019 (USD MILLION)
    • TABLE 51 CONTRAST MEDIA/CONTRAST AGENTS MARKET FOR CARDIOVASCULAR DISORDERS, BY REGION, 2020-2026 (USD MILLION)
  • 9.4 CANCER
    • 9.4.1 ASIA PACIFIC MARKET TO REGISTER RELATIVELY HIGHER GROWTH OWING TO THE HIGH CANCER PREVALENCE IN THE REGION
    • TABLE 52 INCIDENCE OF CANCER, BY REGION, 2020 VS. 2030 VS. 2040 (MILLION)
    • TABLE 53 CONTRAST MEDIA/CONTRAST AGENTS MARKET FOR CANCER, BY REGION, 2017-2019 (USD MILLION)
    • TABLE 54 CONTRAST MEDIA/CONTRAST AGENTS MARKET FOR CANCER, BY REGION, 2020-2026 (USD MILLION)
  • 9.5 GASTROINTESTINAL DISORDERS
    • 9.5.1 RISING PREVALENCE OF GI DISORDERS TO SUPPORT MARKET GROWTH
    • TABLE 55 CONTRAST MEDIA/CONTRAST AGENTS MARKET FOR GASTROINTESTINAL DISORDERS, BY REGION, 2017-2019 (USD MILLION)
    • TABLE 56 CONTRAST MEDIA/CONTRAST AGENTS MARKET FOR GASTROINTESTINAL DISORDERS, BY REGION, 2020-2026 (USD MILLION)
  • 9.6 MUSCULOSKELETAL DISORDERS
    • 9.6.1 RISING INCIDENCE OF WORK-RELATED MUSCULOSKELETAL DISORDERS TO SUPPORT MARKET GROWTH
    • TABLE 57 CONTRAST MEDIA/CONTRAST AGENTS MARKET FOR MUSCULOSKELETAL DISORDERS, BY REGION, 2017-2019 (USD MILLION)
    • TABLE 58 CONTRAST MEDIA/CONTRAST AGENTS MARKET FOR MUSCULOSKELETAL DISORDERS, BY REGION, 2020-2026 (USD MILLION)
  • 9.7 NEUROLOGICAL DISORDERS
    • 9.7.1 RISING PREVALENCE OF DEMENTIA TO DRIVE MARKET GROWTH
    • TABLE 59 CONTRAST MEDIA/CONTRAST AGENTS MARKET FOR NEUROLOGICAL DISORDERS, BY REGION, 2017-2019 (USD MILLION)
    • TABLE 60 CONTRAST MEDIA/CONTRAST AGENTS MARKET FOR NEUROLOGICAL DISORDERS, BY REGION, 2020-2026 (USD MILLION)
  • 9.8 NEPHROLOGICAL DISORDERS
    • 9.8.1 RISING PREVALENCE OF ESRD IS DRIVING THE DEMAND FOR DIAGNOSTIC TOOLS FOR KIDNEY DISEASES
    • TABLE 61 CONTRAST MEDIA/CONTRAST AGENTS MARKET FOR NEPHROLOGICAL DISORDERS, BY REGION, 2017-2019 (USD MILLION)
    • TABLE 62 CONTRAST MEDIA/CONTRAST AGENTS MARKET FOR NEPHROLOGICAL DISORDERS, BY REGION, 2020-2026 (USD MILLION)

10 CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY APPLICATION

  • 10.1 INTRODUCTION
    • TABLE 63 CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY APPLICATION, 2017-2019 (USD MILLION)
    • TABLE 64 CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
  • 10.2 RADIOLOGY
    • 10.2.1 GROWING NUMBER OF DIAGNOSTIC PROCEDURES TO DRIVE THE GROWTH OF THE RADIOLOGY APPLICATIONS SEGMENT
    • TABLE 65 CONTRAST MEDIA/CONTRAST AGENTS MARKET FOR RADIOLOGY, BY REGION, 2017-2019 (USD MILLION)
    • TABLE 66 CONTRAST MEDIA/CONTRAST AGENTS MARKET FOR RADIOLOGY, BY REGION, 2020-2026 (USD MILLION)
  • 10.3 INTERVENTIONAL RADIOLOGY
    • 10.3.1 INCREASING POPULARITY OF MINIMALLY INVASIVE PROCEDURES TO SUPPORT MARKET GROWTH
    • TABLE 67 CONTRAST MEDIA/CONTRAST AGENTS MARKET FOR INTERVENTIONAL RADIOLOGY, BY REGION, 2017-2019 (USD MILLION)
    • TABLE 68 CONTRAST MEDIA/CONTRAST AGENTS MARKET FOR INTERVENTIONAL RADIOLOGY, BY REGION, 2020-2026 (USD MILLION)
  • 10.4 INTERVENTIONAL CARDIOLOGY
    • 10.4.1 RISING INCIDENCE OF CARDIAC DISORDERS TO DRIVE THE DEMAND FOR INTERVENTIONAL CARDIOLOGY PROCEDURES
    • TABLE 69 CONTRAST MEDIA/CONTRAST AGENTS MARKET FOR INTERVENTIONAL CARDIOLOGY, BY REGION, 2017-2019 (USD MILLION)
    • TABLE 70 CONTRAST MEDIA/CONTRAST AGENTS MARKET FOR INTERVENTIONAL CARDIOLOGY, BY REGION, 2020-2026 (USD MILLION)

11 CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY END USER

  • 11.1 INTRODUCTION
    • TABLE 71 CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY END USER, 2017-2019 (USD MILLION)
    • TABLE 72 CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY END USER, 2020-2026 (USD MILLION)
  • 11.2 HOSPITAL, CLINICS, AND AMBULATORY SURGERY CENTERS
    • 11.2.1 INCREASING ADOPTION OF DIAGNOSTIC IMAGING MODALITIES ACROSS HOSPITALS TO DRIVE MARKET GROWTH
    • TABLE 73 CONTRAST MEDIA/CONTRAST AGENTS MARKET FOR HOSPITALS, CLINICS, AND AMBULATORY SURGERY CENTERS, BY REGION, 2017-2019 (USD MILLION)
    • TABLE 74 CONTRAST MEDIA/CONTRAST AGENTS MARKET FOR HOSPITALS, CLINICS, AND AMBULATORY SURGERY CENTERS, BY REGION, 2020-2026 (USD MILLION)
  • 11.3 DIAGNOSTIC IMAGING CENTERS
    • 11.3.1 INCREASING NUMBER OF PRIVATE IMAGING CENTERS TO DRIVE MARKET GROWTH IN THE COMING YEARS
    • TABLE 75 CONTRAST MEDIA/CONTRAST AGENTS MARKET FOR DIAGNOSTIC IMAGING CENTERS, BY REGION, 2017-2019 (USD MILLION)
    • TABLE 76 CONTRAST MEDIA/CONTRAST AGENTS MARKET FOR DIAGNOSTIC IMAGING CENTERS, BY REGION, 2020-2026 (USD MILLION)

12 CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY REGION

  • 12.1 INTRODUCTION
    • TABLE 77 CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY REGION, 2017-2019 (USD MILLION)
    • TABLE 78 CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY REGION, 2020-2026 (USD MILLION)
  • 12.2 NORTH AMERICA
    • FIGURE 29 NORTH AMERICA: CONTRAST MEDIA/CONTRAST AGENTS MARKET SNAPSHOT
    • TABLE 79 NORTH AMERICA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY COUNTRY, 2017-2019 (USD MILLION)
    • TABLE 80 NORTH AMERICA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY COUNTRY, 2020-2026 (USD MILLION)
    • TABLE 81 NORTH AMERICA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY TYPE, 2017-2019 (USD MILLION)
    • TABLE 82 NORTH AMERICA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 83 NORTH AMERICA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY MODALITY, 2017-2019 (USD MILLION)
    • TABLE 84 NORTH AMERICA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY MODALITY, 2020-2026 (USD MILLION)
    • TABLE 85 NORTH AMERICA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2017-2019 (USD MILLION)
    • TABLE 86 NORTH AMERICA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2026 (USD MILLION)
    • TABLE 87 NORTH AMERICA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY INDICATION, 2017-2019 (USD MILLION)
    • TABLE 88 NORTH AMERICA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY INDICATION, 2020-2026 (USD MILLION)
    • TABLE 89 NORTH AMERICA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY APPLICATION, 2017-2019 (USD MILLION)
    • TABLE 90 NORTH AMERICA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • TABLE 91 NORTH AMERICA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY END USER, 2017-2019 (USD MILLION)
    • TABLE 92 NORTH AMERICA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY END USER, 2020-2026 (USD MILLION)
    • 12.2.1 US
      • 12.2.1.1 The US dominates the North American contrast media/contrast agents market
    • TABLE 93 US: KEY MACROINDICATORS
    • TABLE 94 US: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY TYPE, 2017-2019 (USD MILLION)
    • TABLE 95 US: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 96 US: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY MODALITY, 2017-2019 (USD MILLION)
    • TABLE 97 US: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY MODALITY, 2020-2026 (USD MILLION)
    • TABLE 98 US: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2017-2019 (USD MILLION)
    • TABLE 99 US: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2026 (USD MILLION)
    • TABLE 100 US: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY INDICATION, 2017-2019 (USD MILLION)
    • TABLE 101 US: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY INDICATION, 2020-2026 (USD MILLION)
    • TABLE 102 US: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY APPLICATION, 2017-2019 (USD MILLION)
    • TABLE 103 US: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • TABLE 104 US: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY END USER, 2017-2019 (USD MILLION)
    • TABLE 105 US: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY END USER, 2020-2026 (USD MILLION)
    • 12.2.2 CANADA
      • 12.2.2.1 Increasing investments in improving medical imaging-a major factor driving market growth in Canada
    • TABLE 106 CANADA: KEY MACROINDICATORS
    • TABLE 107 CANADA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY TYPE, 2017-2019 (USD MILLION)
    • TABLE 108 CANADA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 109 CANADA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY MODALITY, 2017-2019 (USD MILLION)
    • TABLE 110 CANADA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY MODALITY, 2020-2026 (USD MILLION)
    • TABLE 111 CANADA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2017-2019 (USD MILLION)
    • TABLE 112 CANADA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2026 (USD MILLION)
    • TABLE 113 CANADA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY INDICATION, 2017-2019 (USD MILLION)
    • TABLE 114 CANADA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY INDICATION, 2020-2026 (USD MILLION)
    • TABLE 115 CANADA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY APPLICATION, 2017-2019 (USD MILLION)
    • TABLE 116 CANADA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • TABLE 117 CANADA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY END USER, 2017-2019 (USD MILLION)
    • TABLE 118 CANADA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY END USER, 2020-2026 (USD MILLION)
  • 12.3 EUROPE
    • TABLE 119 TOTAL NUMBER OF MRI UNITS PER 1,000,000 INHABITANTS, 2017
    • TABLE 120 TOTAL NUMBER OF MRI EXAMS PER 1,000 INHABITANTS, 2017
    • TABLE 121 EUROPE: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY COUNTRY, 2017-2019 (USD MILLION)
    • TABLE 122 EUROPE: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY COUNTRY, 2020-2026 (USD MILLION)
    • TABLE 123 EUROPE: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY TYPE, 2017-2019 (USD MILLION)
    • TABLE 124 EUROPE: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 125 EUROPE: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY MODALITY, 2017-2019 (USD MILLION)
    • TABLE 126 EUROPE: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY MODALITY, 2020-2026 (USD MILLION)
    • TABLE 127 EUROPE: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2017-2019 (USD MILLION)
    • TABLE 128 EUROPE: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2026 (USD MILLION)
    • TABLE 129 EUROPE: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY INDICATION, 2017-2019 (USD MILLION)
    • TABLE 130 EUROPE: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY INDICATION, 2020-2026 (USD MILLION)
    • TABLE 131 EUROPE: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY APPLICATION, 2017-2019 (USD MILLION)
    • TABLE 132 EUROPE: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • TABLE 133 EUROPE: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY END USER, 2017-2019 (USD MILLION)
    • TABLE 134 EUROPE: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY END USER, 2020-2026 (USD MILLION)
    • 12.3.1 GERMANY
      • 12.3.1.1 Presence of a well-developed diagnostic imaging infrastructure is a major factor supporting market growth in Germany
    • TABLE 135 GERMANY: KEY MACROINDICATORS
    • TABLE 136 GERMANY: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY TYPE, 2017-2019 (USD MILLION)
    • TABLE 137 GERMANY: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 138 GERMANY: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY MODALITY, 2017-2019 (USD MILLION)
    • TABLE 139 GERMANY: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY MODALITY, 2020-2026 (USD MILLION)
    • TABLE 140 GERMANY: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2017-2019 (USD MILLION)
    • TABLE 141 GERMANY: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2026 (USD MILLION)
    • TABLE 142 GERMANY: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY INDICATION, 2017-2019 (USD MILLION)
    • TABLE 143 GERMANY: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY INDICATION, 2020-2026 (USD MILLION)
    • TABLE 144 GERMANY: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY APPLICATION, 2017-2019 (USD MILLION)
    • TABLE 145 GERMANY: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • TABLE 146 GERMANY: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY END USER, 2017-2019 (USD MILLION)
    • TABLE 147 GERMANY: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY END USER, 2020-2026 (USD MILLION)
    • 12.3.2 UK
      • 12.3.2.1 Increasing investments in the field of diagnostic imaging to boost the market growth
    • TABLE 148 UK: KEY MACROINDICATORS
    • TABLE 149 UK: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY TYPE, 2017-2019 (USD MILLION)
    • TABLE 150 UK: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 151 UK: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY MODALITY, 2017-2019 (USD MILLION)
    • TABLE 152 UK: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY MODALITY, 2020-2026 (USD MILLION)
    • TABLE 153 UK: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2017-2019 (USD MILLION)
    • TABLE 154 UK: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2026 (USD MILLION)
    • TABLE 155 UK: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY INDICATION, 2017-2019 (USD MILLION)
    • TABLE 156 UK: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY INDICATION, 2020-2026 (USD MILLION)
    • TABLE 157 UK: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY APPLICATION, 2017-2019 (USD MILLION)
    • TABLE 158 UK: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • TABLE 159 UK: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY END USER, 2017-2019 (USD MILLION)
    • TABLE 160 UK: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY END USER, 2020-2026 (USD MILLION)
    • 12.3.3 FRANCE
      • 12.3.3.1 Increasing prevalence of cancer will drive the market for contrast media in France
    • TABLE 161 FRANCE: KEY MACROINDICATORS
    • TABLE 162 FRANCE: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY TYPE, 2017-2019 (USD MILLION)
    • TABLE 163 FRANCE: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 164 FRANCE: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY MODALITY, 2017-2019 (USD MILLION)
    • TABLE 165 FRANCE: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY MODALITY, 2020-2026 (USD MILLION)
    • TABLE 166 FRANCE: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2017-2019 (USD MILLION)
    • TABLE 167 FRANCE: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2026 (USD MILLION)
    • TABLE 168 FRANCE: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY INDICATION, 2017-2019 (USD MILLION)
    • TABLE 169 FRANCE: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY INDICATION, 2020-2026 (USD MILLION)
    • TABLE 170 FRANCE: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY APPLICATION, 2017-2019 (USD MILLION)
    • TABLE 171 FRANCE: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • TABLE 172 FRANCE: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY END USER, 2017-2019 (USD MILLION)
    • TABLE 173 FRANCE: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY END USER, 2020-2026 (USD MILLION)
    • 12.3.4 SPAIN
      • 12.3.4.1 Shortage of radiologists in the country to restrain the market growth
    • TABLE 174 SPAIN: KEY MACROINDICATORS
    • TABLE 175 SPAIN: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY TYPE, 2017-2019 (USD MILLION)
    • TABLE 176 SPAIN: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 177 SPAIN: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY MODALITY, 2017-2019 (USD MILLION)
    • TABLE 178 SPAIN: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY MODALITY, 2020-2026 (USD MILLION)
    • TABLE 179 SPAIN: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2017-2019 (USD MILLION)
    • TABLE 180 SPAIN: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2026 (USD MILLION)
    • TABLE 181 SPAIN: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY INDICATION, 2017-2019 (USD MILLION)
    • TABLE 182 SPAIN: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY INDICATION, 2020-2026 (USD MILLION)
    • TABLE 183 SPAIN: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY APPLICATION, 2017-2019 (USD MILLION)
    • TABLE 184 SPAIN: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • TABLE 185 SPAIN: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY END USER, 2017-2019 (USD MILLION)
    • TABLE 186 SPAIN: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY END USER, 2020-2026 (USD MILLION)
    • 12.3.5 ITALY
      • 12.3.5.1 Rising geriatric population likely to drive the demand for diagnostic procedures in Italy
    • TABLE 187 ITALY: KEY MACROINDICATORS
    • TABLE 188 ITALY: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY TYPE, 2017-2019 (USD MILLION)
    • TABLE 189 ITALY: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 190 ITALY: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY MODALITY, 2017-2019 (USD MILLION)
    • TABLE 191 ITALY: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY MODALITY, 2020-2026 (USD MILLION)
    • TABLE 192 ITALY: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2017-2019 (USD MILLION)
    • TABLE 193 ITALY: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2026 (USD MILLION)
    • TABLE 194 ITALY: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY INDICATION, 2017-2019 (USD MILLION)
    • TABLE 195 ITALY: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY INDICATION, 2020-2026 (USD MILLION)
    • TABLE 196 ITALY: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY APPLICATION, 2017-2019 (USD MILLION)
    • TABLE 197 ITALY: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • TABLE 198 ITALY: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY END USER, 2017-2019 (USD MILLION)
    • TABLE 199 ITALY: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY END USER, 2020-2026 (USD MILLION)
    • 12.3.6 REST OF EUROPE
    • TABLE 200 ROE: HEALTHCARE EXPENDITURE, BY COUNTRY, 2010 VS. 2018 (% OF GDP)
    • TABLE 201 ROE: NUMBER OF UNITS AND NUMBER OF SCANS, BY COUNTRY, 2018
    • TABLE 202 ROE: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY TYPE, 2017-2019 (USD MILLION)
    • TABLE 203 ROE: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 204 ROE: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY MODALITY, 2017-2019 (USD MILLION)
    • TABLE 205 ROE: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY MODALITY, 2020-2026 (USD MILLION)
    • TABLE 206 ROE: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2017-2019 (USD MILLION)
    • TABLE 207 ROE: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2026 (USD MILLION)
    • TABLE 208 ROE: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY INDICATION, 2017-2019 (USD MILLION)
    • TABLE 209 ROE: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY INDICATION, 2020-2026 (USD MILLION)
    • TABLE 210 ROE: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY APPLICATION, 2017-2019 (USD MILLION)
    • TABLE 211 ROE: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • TABLE 212 ROE: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY END USER, 2017-2019 (USD MILLION)
    • TABLE 213 ROE: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY END USER, 2020-2026 (USD MILLION)
  • 12.4 ASIA PACIFIC
    • FIGURE 30 ASIA PACIFIC: CONTRAST MEDIA/CONTRAST AGENTS MARKET SNAPSHOT
    • TABLE 214 APAC: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY COUNTRY, 2017-2019 (USD MILLION)
    • TABLE 215 APAC: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY COUNTRY, 2020-2026 (USD MILLION)
    • TABLE 216 APAC: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY TYPE, 2017-2019 (USD MILLION)
    • TABLE 217 APAC: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 218 APAC: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY MODALITY, 2017-2019 (USD MILLION)
    • TABLE 219 APAC: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY MODALITY, 2020-2026 (USD MILLION)
    • TABLE 220 APAC: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2017-2019 (USD MILLION)
    • TABLE 221 APAC: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2026 (USD MILLION)
    • TABLE 222 APAC: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY INDICATION, 2017-2019 (USD MILLION)
    • TABLE 223 APAC: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY INDICATION, 2020-2026 (USD MILLION)
    • TABLE 224 APAC: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY APPLICATION, 2017-2019 (USD MILLION)
    • TABLE 225 APAC: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • TABLE 226 APAC: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY END USER, 2017-2019 (USD MILLION)
    • TABLE 227 APAC: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY END USER, 2020-2026 (USD MILLION)
    • 12.4.1 JAPAN
      • 12.4.1.1 Japan dominates the APAC contrast media/contrast agents market
    • TABLE 228 JAPAN: KEY MACROINDICATORS
    • TABLE 229 JAPAN: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY TYPE, 2017-2019 (USD MILLION)
    • TABLE 230 JAPAN: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 231 JAPAN: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY MODALITY, 2017-2019 (USD MILLION)
    • TABLE 232 JAPAN: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY MODALITY, 2020-2026 (USD MILLION)
    • TABLE 233 JAPAN: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2017-2019 (USD MILLION)
    • TABLE 234 JAPAN: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2026 (USD MILLION)
    • TABLE 235 JAPAN: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY INDICATION, 2017-2019 (USD MILLION)
    • TABLE 236 JAPAN: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY INDICATION, 2020-2026 (USD MILLION)
    • TABLE 237 JAPAN: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY APPLICATION, 2017-2019 (USD MILLION)
    • TABLE 238 JAPAN: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • TABLE 239 JAPAN: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY END USER, 2017-2019 (USD MILLION)
    • TABLE 240 JAPAN: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY END USER, 2020-2026 (USD MILLION)
    • 12.4.2 CHINA
      • 12.4.2.1 High incidence of cancer and strokes will support the market for contrast media in China
    • TABLE 241 CHINA: KEY MACROINDICATORS
    • TABLE 242 CHINA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY TYPE, 2017-2019 (USD MILLION)
    • TABLE 243 CHINA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 244 CHINA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY MODALITY, 2017-2019 (USD MILLION)
    • TABLE 245 CHINA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY MODALITY, 2020-2026 (USD MILLION)
    • TABLE 246 CHINA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2017-2019 (USD MILLION)
    • TABLE 247 CHINA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2026 (USD MILLION)
    • TABLE 248 CHINA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY INDICATION, 2017-2019 (USD MILLION)
    • TABLE 249 CHINA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY INDICATION, 2020-2026 (USD MILLION)
    • TABLE 250 CHINA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY APPLICATION, 2017-2019 (USD MILLION)
    • TABLE 251 CHINA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • TABLE 252 CHINA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY END USER, 2017-2019 (USD MILLION)
    • TABLE 253 CHINA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY END USER, 2020-2026 (USD MILLION)
    • 12.4.3 INDIA
      • 12.4.3.1 Growing investments in the Indian radiology market will propel market growth
    • TABLE 254 INDIA: KEY MACROINDICATORS
    • TABLE 255 INDIA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY TYPE, 2017-2019 (USD MILLION)
    • TABLE 256 INDIA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 257 INDIA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY MODALITY, 2017-2019 (USD MILLION)
    • TABLE 258 INDIA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY MODALITY, 2020-2026 (USD MILLION)
    • TABLE 259 INDIA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2017-2019 (USD MILLION)
    • TABLE 260 INDIA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2026 (USD MILLION)
    • TABLE 261 INDIA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY INDICATION, 2017-2019 (USD MILLION)
    • TABLE 262 INDIA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY INDICATION, 2020-2026 (USD MILLION)
    • TABLE 263 INDIA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY APPLICATION, 2017-2019 (USD MILLION)
    • TABLE 264 INDIA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • TABLE 265 INDIA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY END USER, 2017-2019 (USD MILLION)
    • TABLE 266 INDIA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY END USER, 2020-2026 (USD MILLION)
    • 12.4.4 REST OF ASIA PACIFIC
    • TABLE 267 NUMBER OF MRI AND CT UNITS PER MILLION POPULATION, PER COUNTRY, 2019
    • TABLE 268 ROAPAC: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY TYPE, 2017-2019 (USD MILLION)
    • TABLE 269 ROAPAC: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 270 ROAPAC: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY MODALITY, 2017-2019 (USD MILLION)
    • TABLE 271 ROAPAC: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY MODALITY, 2020-2026 (USD MILLION)
    • TABLE 272 ROAPAC: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2017-2019 (USD MILLION)
    • TABLE 273 ROAPAC: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2026 (USD MILLION)
    • TABLE 274 ROAPAC: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY INDICATION, 2017-2019 (USD MILLION)
    • TABLE 275 ROAPAC: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY INDICATION, 2020-2026 (USD MILLION)
    • TABLE 276 ROAPAC: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY APPLICATION, 2017-2019 (USD MILLION)
    • TABLE 277 ROAPAC: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • TABLE 278 ROAPAC: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY END USER, 2017-2019 (USD MILLION)
    • TABLE 279 ROAPAC: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY END USER, 2020-2026 (USD MILLION)
  • 12.5 LATIN AMERICA
    • 12.5.1 INCREASING HEALTHCARE ACCESS IS EXPECTED TO DRIVE MARKET GROWTH
    • TABLE 280 LATIN AMERICA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY TYPE, 2017-2019 (USD MILLION)
    • TABLE 281 LATIN AMERICA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 282 LATIN AMERICA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY MODALITY, 2017-2019 (USD MILLION)
    • TABLE 283 LATIN AMERICA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY MODALITY, 2020-2026 (USD MILLION)
    • TABLE 284 LATIN AMERICA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2017-2019 (USD MILLION)
    • TABLE 285 LATIN AMERICA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2026 (USD MILLION)
    • TABLE 286 LATIN AMERICA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY INDICATION, 2017-2019 (USD MILLION)
    • TABLE 287 LATIN AMERICA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY INDICATION, 2020-2026 (USD MILLION)
    • TABLE 288 LATIN AMERICA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY APPLICATION, 2017-2019 (USD MILLION)
    • TABLE 289 LATIN AMERICA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • TABLE 290 LATIN AMERICA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY END USER, 2017-2019 (USD MILLION)
    • TABLE 291 LATIN AMERICA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY END USER, 2020-2026 (USD MILLION)
  • 12.6 MIDDLE EAST & AFRICA
    • 12.6.1 POOR REIMBURSEMENT SYSTEMS EXPECTED TO RESTRAIN MARKET GROWTH
    • TABLE 292 ISRAEL: DIAGNOSTIC IMAGING DATA, 2019
    • TABLE 293 MEA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY TYPE, 2017-2019 (USD MILLION)
    • TABLE 294 MEA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY TYPE, 2020-2026 (USD MILLION)
    • TABLE 295 MEA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY MODALITY, 2017-2019 (USD MILLION)
    • TABLE 296 MEA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY MODALITY, 2020-2026 (USD MILLION)
    • TABLE 297 MEA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2017-2019 (USD MILLION)
    • TABLE 298 MEA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2026 (USD MILLION)
    • TABLE 299 MEA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY INDICATION, 2017-2019 (USD MILLION)
    • TABLE 300 MEA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY INDICATION, 2020-2026 (USD MILLION)
    • TABLE 301 MEA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY APPLICATION, 2017-2019 (USD MILLION)
    • TABLE 302 MEA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • TABLE 303 MEA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY END USER, 2017-2019 (USD MILLION)
    • TABLE 304 MEA: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY END USER, 2020-2026 (USD MILLION)

13 COMPETITIVE LANDSCAPE

  • 13.1 OVERVIEW
  • 13.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    • TABLE 305 OVERVIEW OF STRATEGIES ADOPTED BY KEY CONTRAST MEDIA/CONTRAST AGENTS MARKET PLAYERS
  • 13.3 MARKET SHARE ANALYSIS
    • FIGURE 31 CONTRAST MEDIA/CONTRAST AGENTS MARKET SHARE ANALYSIS, 2020
    • TABLE 306 CONTRAST MEDIA/CONTRAST AGENTS MARKET: DEGREE OF COMPETITION (2020)
  • 13.4 COMPANY EVALUATION QUADRANT
    • 13.4.1 STARS
    • 13.4.2 EMERGING LEADERS
    • 13.4.3 PERVASIVE PLAYERS
    • 13.4.4 PARTICIPANTS
    • FIGURE 32 CONTRAST MEDIA/CONTRAST AGENTS MARKET: COMPANY EVALUATION QUADRANT, 2020
  • 13.5 COMPANY EVALUATION QUADRANT: SME/START-UPS
    • 13.5.1 PROGRESSIVE COMPANIES
    • 13.5.2 STARTING BLOCKS
    • 13.5.3 RESPONSIVE COMPANIES
    • 13.5.4 DYNAMIC COMPANIES
    • FIGURE 33 CONTRAST MEDIA/CONTRAST AGENTS MARKET: COMPANY EVALUATION QUADRANT FOR SME & START-UPS, 2020
  • 13.6 COMPETITIVE SCENARIO
    • FIGURE 34 MARKET EVALUATION MATRIX, 2018-2021
    • 13.6.1 DEALS
    • TABLE 307 DEALS
    • 13.6.2 PRODUCT LAUNCHES/APPROVALS
    • TABLE 308 PRODUCT LAUNCHES/APPROVALS
    • 13.6.3 OTHER DEVELOPMENTS
    • TABLE 309 OTHER DEVELOPMENTS
  • 13.7 COMPANY FOOTPRINT ANALYSIS
    • TABLE 310 COMPANY FOOTPRINT ANALYSIS
    • TABLE 311 COMPANY PRODUCT FOOTPRINT
    • TABLE 312 COMPANY MODALITY FOOTPRINT
    • TABLE 313 COMPANY GEOGRAPHICAL FOOTPRINT

14 COMPANY PROFILES

  • 14.1 KEY PLAYERS
  • (Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))**
    • 14.1.1 GE HEALTHCARE
    • TABLE 314 GE HEALTHCARE: BUSINESS OVERVIEW
    • FIGURE 35 GE HEALTHCARE: COMPANY SNAPSHOT (2020)
    • 14.1.2 BRACCO IMAGING SPA
    • TABLE 315 BRACCO IMAGING SPA: BUSINESS OVERVIEW
    • 14.1.3 BAYER AG
    • TABLE 316 BAYER AG: BUSINESS OVERVIEW
    • FIGURE 36 BAYER AG: COMPANY SNAPSHOT (2020)
    • 14.1.4 GUERBET
    • TABLE 317 GUERBET: BUSINESS OVERVIEW
    • FIGURE 37 GUERBET: COMPANY SNAPSHOT (2020)
    • 14.1.5 LANTHEUS MEDICAL IMAGING
    • TABLE 318 LANTHEUS MEDICAL IMAGING: BUSINESS OVERVIEW
    • FIGURE 38 LANTHEUS MEDICAL IMAGING: COMPANY SNAPSHOT (2020)
    • 14.1.6 UNIJULES LIFE SCIENCES
    • TABLE 319 UNIJULES LIFE SCIENCES: BUSINESS OVERVIEW
    • 14.1.7 J.B. CHEMICALS AND PHARMACEUTICALS
    • TABLE 320 J.B. CHEMICALS AND PHARMACEUTICALS: BUSINESS OVERVIEW
    • FIGURE 39 J.B. CHEMICALS AND PHARMACEUTICALS LTD: COMPANY SNAPSHOT (2020)
    • 14.1.8 SANOCHEMIA PHARMAZEUTIKA
    • TABLE 321 SANOCHEMIA PHARMAZEUTIKA: BUSINESS OVERVIEW
    • 14.1.9 TAEJOON PHARM
    • TABLE 322 TAEJOON PHARM: BUSINESS OVERVIEW
    • 14.1.10 JODAS EXPOIM
    • TABLE 323 JODAS EXPOIM: BUSINESS OVERVIEW
    • 14.1.11 NANO THERAPEUTICS
    • TABLE 324 NANO THERAPEUTICS: BUSINESS OVERVIEW
    • 14.1.12 KIRAN X-RAY
    • TABLE 325 KIRAN X-RAY: BUSINESS OVERVIEW
    • 14.1.13 IMAX DIAGNOSTIC IMAGING LIMITED
    • TABLE 326 IMAX DIAGNOSTIC IMAGING: BUSINESS OVERVIEW
    • 14.1.14 YANGTZE RIVER PHARMACEUTICAL GROUP
    • TABLE 327 YZJ GROUP: BUSINESS OVERVIEW
    • 14.1.15 LIVEALTH BIOPHARMA
    • TABLE 328 LIVEALTH BIOPHARMA: BUSINESS OVERVIEW
  • 14.2 OTHER PLAYERS
    • 14.2.1 TRIVITRON HEALTHCARE
    • 14.2.2 NOVALEK PHARMACEUTICALS
    • 14.2.3 UNISPIRE BIOPHARMA PRIVATE LIMITED
    • 14.2.4 ARCO LIFESCIENCES
    • 14.2.5 CONGRUENT PHARMACHEM PRIVATE LIMITED
    • 14.2.6 STANEX DRUGS & CHEMICAL
    • 14.2.7 BEIJING BEILU PHARMACEUTICAL
    • 14.2.8 REGE IMAGING & CINE FILMS
    • 14.2.9 K DIAM EXIM
    • 14.2.10 ONKO ILAC SAN. VE TIC. A.S.
    • 14.2.11 SUBHRA PHARMA
  • *Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

15 APPENDIX

  • 15.1 INSIGHTS FROM INDUSTRY EXPERTS
  • 15.2 DISCUSSION GUIDE
  • 15.3 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 15.4 AVAILABLE CUSTOMIZATIONS
  • 15.5 RELATED REPORTS
  • 15.6 AUTHOR DETAILS
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!